CTHRC1 as a Novel Regulatory Target of Type I Collagen Synthesis via ATF4 in Pulmonary Fibrosis
Year: 2026
Type: article
Abstract: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by excessive deposition of extracellular matrix, primarily type I collagen. This study investigates the role of Collagen triple helix repeat containing 1 (CTHRC1) in pulmonary fibrosis. Analysis of public databases and validation in mouse models revealed that CTHRC1 expression is significantly upregulated and strongly correlates with type I collagen. Single-cell RNA sequencing and immunofluorescence supported a close association between CTHRC1 and myofibroblasts in fibrotic lungs. In vitro, CTHRC1 knockdown in NIH3T3 fibroblasts attenuated TGF-β1-induced type I collagen production. Mechanistically, CTHRC1 silencing reduced phosphorylation of the TGF-β receptor I and its downstream effectors Smad2/3, accompanied by reduced protein expression of the transcription factor ATF4 and its target, the collagen synthesis enzyme PSAT1. These findings support a CTHRC1–TGF-β/Smad–ATF4/PSAT1 signaling model for type I collagen regulation, providing a basis for further investigation of CTHRC1 and the associated pathway as potential therapeutic targets in IPF.
Source: Molecules
Institutions: China Agricultural University, Chinese PLA General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,258
Awards: G1773702449, G5834948321
OpenAlex ID: W7225879133
